Abstract
The authors followed the guidelines of translation and pilot testing of the EORTC QLQ-C30 and EORTC-QLQ-H&N35 questionnaires. The questionnaires were given to 50 nasopharyngeal carcinoma patients under active treatment and 50 under follow-up at our institution from November 2000 to June 2001. A retest was conducted 2 weeks after the first interview/form completion for the follow-up group. The intraclass correlation coefficients of the two questionnaires were moderate to high in the follow-up group. Cronbach's α coefficients of all scales of the two questionnaires were ≥ 0.70 except that of cognitive functioning. Correlation of scales measuring similar dimensions of the QLQ-C30 and the SF-36 were moderate to high, while that of the QLQ-H&N35 and the QLQ-C30 and the SF-36 were moderate to low. Patients in the active treatment group had more serious acute problems due to disease and chemotherapy. Patients in the follow-up group had more serious chronic problems due to radiation therapy. We concluded that the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35 had moderate to high test–retest reliability, high internal consistency in most scales, and could show the expected differences between patients in active treatment and follow-up group.
References
Cheng YJ, Hildesheim A, Hsu MM, et al. Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control 1999; 10: 201–207.
Department of Health, the Executive Yuan. Cancer Registry Annual Report, Republic of China, 1997. Taipei: Department of Health. 2000; 20–21.
Division of Cancer Research, National Health Research Institutes and Taiwan Cooperative Organization of Cancer. Consensus of Diagnosis and Treatment of Nasopharyngeal Carcinoma. Taipei: National Health Research Institutes, 2000.
Aaronson NK, Ahmedzai A, Berman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365–376.
Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S. Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 1995; 13: 1249–1254.
Groenvold M, Klee MC, Sprangers MAG, Aaronson NK. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol 1997; 50: 441–450.
Kobayashi K, Takeda F, Teramukai S, et al. A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. Eur J Cancer 1998; 34: 810–815.
Bjordal K, Kaasa S. Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol 1992; 31: 311–321.
Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al. Quality of life in head and neck cancer patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 1999; 17: 1008–1019.
Bjordal K, de Graeff A, Fayers PM, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. Eur J Cancer 2000; 36: 1796–1807.
Sherman AC, Simonton S, Adams DC, Vural E, Owens B, Hanna E. Assessing quality of life in patients with head and neck cancer, cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck Module (QLQ-H&N35). Arch Otolaryngol Head Neck Surg 2000; 126: 459–467.
EORTC quality of Life Study Group. Questionnaire for the Department of Obstetric and gynecology, Hong Kong University (Chinese Translation of the EORTC QLQ-C30 version 2.0). Brussels: Quality of Life Unit, EORTC Data Center, 1997.
Cull A, Sprangers M, Bjordal K, et al. EORTC Quality of Life Study Group Translation Procedure. Brussels: EORTC Quality of Life Study Group, 1998.
New England Medical Center Hospital. IQOLA SF-36 Taiwan Standard Version 1.0. Boston: The Health Institute, New England Medical Center, 1996.
Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston: The Health Institute, New England Medical Center, 1994.
Chie WC, Huang CS, Chen JH, Chang KJ. Measurement of the quality of life during different clinical phases of breast cancer. J Formos Med Assoc 1999; 98: 254–260.
Fuh JL, Wang SJ, Lu SR, Juang KD, Lee SJ. Psychometric evaluation of a Chinese (Taiwanese) Version of the SF-36 Health Survey amongst middle-aged women from a rural community. Qual Life Res 2000; 9: 675–683.
Chiu HC, Chern JY, Shi HY, Chen SH, Chang JK. Physical functioning and health-related quality of life: Before and after total hip replacement. Kaohsiung J Med Sci 2000; 16: 285–292.
Wang SJ, Fuh JL, Lu SR, Juang KD. Quality of life differs among headache diagnoses: Analysis of SF-36 survey in 901 headache patients. Pain 2001; 89: 285–292.
Streiner DL, Norman GR. Reliability, in Streiner DL, Norman GR (eds): Health Measurement Scales. A Practical Guide to Their Development and Use. Oxford: Oxford Medical, 1994; 79–96.
Fayers P, Aaronson N, Bjordal K, Curran D, Groenvold M: EORTC QLQ-C30 Scoring Manual. 2nd ed. Brussels: EORTC Quality of Life Study Group, 1999.
Fayers P, Weeden S, Curran D. EORTC QLQ-C30 Reference Values. Brussels: EORTC Quality of Life Study Group, 1998.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chie, WC., Hong, RL., Lai, CC. et al. Quality of life in patients of nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35. Qual Life Res 12, 93–98 (2003). https://doi.org/10.1023/A:1022070220328
Issue Date:
DOI: https://doi.org/10.1023/A:1022070220328